Short term effectiveness of a novel nutraceutical for the management of hypercholesterolemia in patients with low to moderate cardiovascular risk: a multicenter primary care observational
Anno:
2023
Purpose: Increasing evidence reinforces the benefits of reduction of low-density lipoprotein (LDL-C) levels on cardiovascular outcomes. Different targets are suggested based on cardiovascular risk (CVR). According to the current European guidelines, a goal of LDL-C≤ 115mg/dL is desirable for patients with low-moderate CVR. However, a high percentage of these…